Background: We hypothesized that spleen microarray gene expression profiles analyzed with
INTRODUCTION
The bcl-2 family of proteins currently includes over 15 members that function either in an anti-apoptotic or a pro-apoptotic fashion. (14) The founding member of this family, bcl-2, was discovered by serendipity during investigation of patients with follicular non-Hodgkin's B-cell lymphoma in which chromosomal translocations activate the bcl-2 gene (6, 42) . A number of investigators have demonstrated that overexpression of bcl-2 can prevent apoptotic death in many types of cells from an array of insults (growth factor withdrawal, radiation, hypoxia, ionomycin, glucocorticoids, etc.) (29, 30, 32, 35, 40) . Importantly, bcl-2 has proven capable of blocking cell death not only in vitro but also in vivo. For example, transgenic mice in which bcl-2 has been selectively overexpressed in the cell of interest are protected against brain ischemia, neurotoxins, fas-mediated hepatic necrosis, and other injuries (4, 29, 30, 32) .
A number of laboratories, including our own, demonstrated that overexpression of the anti-apoptotic protein bcl-2 in lymphocytes abrogated sepsis-induced lymphocyte apoptosis and caused a dramatic increase in survival (17, 25) . In addition, Iwata and associates showed in mice that overexpression of bcl-2 in myeloid derived cells (circulating neutrophils and monocytes) also demonstrated improved survival in sepsis (26) . Although bcl-2 is postulated to block apoptosis by preventing loss of mitochondrial membrane potential, subsequent investigations have implicated other possible anti-apoptotic mechanisms, including binding/inactivating proapoptotic bcl-2 family members and regulation of endoplasmic reticulum calcium release (28) .
In order to explore the potential anti-apoptotic mechanisms responsible for the beneficial effects of bcl-2 in sepsis, we performed a survey of transcriptional changes induced by sepsis in mouse spleens (a site of a high degree of apoptotic cell death). We hypothesized that spleen microarray gene expression profiles coupled with contemporary pathway analysis software could reduce the genome-wid e space of potential gene-gene interactions, (2) providing novel molecular insight and direction for future investigations. To increase confidence in the analysis, two clinically relevant mouse models of sepsis (cecal ligation and puncture and pneumonia) were tested in both wild-type mice and mice that overexpress bcl-2. In silico network analysis was used to identify informational genes, the importance of which was validated in subsequent studies (3, 22) .
METHODS

Animals:
Mice that were heterozygous for the H2K-Bcl-2 transgene on a C57BL/Ka Thy-1.1, CD45.2 background were kindly provided by Dr. Irving Weissman (8, 9) . The H2K promoter induces expression of human bcl-2 in hematopoietic stem cells with resultant expression in both lymphoid and myeloid derived cells. Thus, human bcl-2 is expressed in lymphocytes, monocytes, and granulocytes. These mice were backcrossed seven generations onto a C57BL6 background. Male heterozygous mice (5-15 weeks old) were used in all studies in order to avoid confounding effects of changes occurring during the estrus cycle. Flow cytometry and immunostaining for human bcl-2 of circulating peripheral blood cells was used to identify mice heterozygous for the H2K-Bcl-2 transgene (data not shown). Control wild type mice for CLP were either male C57BL6 mice purchased from Jackson laboratories (Bar Harbor ME, 04609) or non-transgenic littermates. Control animals for the pneumonia experiments were all non-transgenic littermates.
Sepsis Models: Animal care and use protocols were approved by the Animal Studies Committee at Washington University School of Medicine. The cecal ligation and puncture (CLP) murine model that reproduces many of the clinical features of sepsis in patients was used to induce intra-abdominal peritonitis (1). As reported previously, blood cultures are positive for numerous aerobic and anaerobic Gram-positive and Gram-negative bacteria in CLP but are not positive in sham operated mice (20) . Six mice were anesthetized with halothane and a midline abdominal incision was made. The cecum was mobilized, ligated below the ileocecal valve, and punctured twice with a 23-gauge needle. The abdomen was closed in two layers, and the mice were injected subcutaneously with 2.0 ml of 0.9% saline. Six sham-operated mice were handled in the same manner, except that the cecum was not ligated or punctured.
The ATCC 27853 strain of Pseudomonas aeruginosa was used to induce pneumonia as described previously (21) . In brief, organisms were grown overnight in trypticase soy broth with constant shaking. A 10 mL volume of the culture medium was placed in a 50 ml conical tube and the cells were harvested by centrifugation for 10 min. at 6,000 x g. The final density of the inoculum was adjusted to 0.3 A 600 nm , corresponding to a cell density ranging between 5 x 10 8 and 1 x 10 9 CFU/ml as determined by serial dilution and colony counts. Pseudomonas pneumonia (n=5) could be determined compared to their controls (n=6 and 5, respectively), and the effect of bcl-2 overexpression in turn also could be determined in both CLP (n=5) and pneumonia models (n=5) compared to controls (n=5 and 5, respectively, see experimental groups and comparisons in Figure 1 ).
Preparation of mRNA: Splenic total RNA was isolated using TRIzol reagent (Invitrogen Corporation, Carlsbad, California 92008) followed by cleanup on RNeasy spin columns (QIAGEN, Inc., Valencia CA 91355). Quality and yield of RNA were determined using the 2100 Bioanalyzer (Agilent Technologies, Inc., Palo Alto, CA 94306). Using previously reported protocols, (7) cRNA was prepared and hybridized with the Mouse Expression Array 430A GeneChip (Affymetrix, Santa Clara, CA 95051) to measure relative changes in RNA abundance. GeneChip data were deposited in the Gene Expression Omnibus (GEO, www.ncbi.nlm.nih.gov/geo/ ), accession number GSE5811.
GeneChip Analysis: Normalized, perfect-match model-based expression values were calculated from all 42 GeneChip .cel files using DNA chip analyzer (dChip) software (31) .
Principal components analysis (PCA) was performed using all genes to explore microarray (data not shown). Thus, data from non-transgenic litter mates and similarly treated purchased C57BL/6 mice were combined for further analysis.
Effect of bcl-2 over-expression and experimental procedures in control animals:
The effects of the bcl-2 transgene and control procedures on splenocyte expression profiles were gauged by comparing differences between control groups, specifically the effect of sham laparotomy or the effect of saline tracheal infection in wild type and bcl-2 transgenic animals.
Hundreds of probe sets differed in response to sham and saline treatment manipulations in either wild type or bcl-2 transgenic animals (affect of general anesthesia and surgery, Table 1 ).
Specifically, bcl-2 overexpression altered 230 probe sets in the sham surgical group and 417 probe sets in the saline control group. Of these, RNA abundance for 27 probe sets was altered comparing wild type to bcl-2 transgenic controls, regardless of whether the treatment was sham laparotomy or tracheal instillation of saline (that is, the effect of bcl-2 overexpression in control animals, Figure 1C , bottom circle). As expected, the abundance of bcl-2 transcript was increased in bcl-2 transgenic animals, approximately 3.6 fold. The only other gene demonstrating increased abundance was a gene associated with neuroblastomas, v-myc (myelocytomatosis viral-related oncogene), up approximately 7.7 fold in bcl-2 transgenics compared to wild-type animals. RNA abundance of the other genes identified was decreased by 2.5 fold or less.
Pathway analysis software did not identify network interactions among these probe sets.
Effect of sepsis secondary to CLP and Pseudomonas pneumonia:
Bacterial sepsis secondary to CLP or pneumonia induced marked differences in splenocyte relative mRNA abundance at 6 hours compared to their respective controls ( Table 1) . Regardless of genetic background, hundreds to thousands of probe sets were altered using an FDR of 0.01. In each treatment-control comparison, the majority of changes in expression profiles were decreases in relative RNA abundance. To determine the common effects of sepsis on splenocytes regardless of infection source or genotype, the gene lists from Table 1 were compared (Figure 1 ).
To increase confidence in the functional analysis of these comparisons, a conservative approach was used wherein only alterations in RNA abundance that occurred in both the CLP and pneumonia models were studied ( Figure 1 revealed a large number of interactions among apoptosis genes that were altered by bcl-2 overexpression, including bcl2L11 (bim), mcl-1, bcl2L2 (bcl-w), and bmf ( Figure 4 and Table 2 ).
These findings in turn directed subsequent experiments aimed at better elucidating mechanism, as reported elsewhere (e.g., targeted gene deletion of bcl2L11 (bim) and administration of TATBcl-xL constructs) (3, 22) .
DISCUSSION
Sepsis induces extensive lymphocyte and dendritic cell apoptosis that alters immune responsiveness by three mechanisms: 1) profound depletion of immune effector cells, 2) uptake of apoptotic cells causing anti-inflammatory/immunosuppressive effect on surviving cells, and 3) decreased clearance of invading organisms (19, 44, 45) . The molecular mechanisms by which bcl-2 alters cell survival in sepsis remains controversial (18, 27, 36) . We hypothesized that microarray analysis coupled with contemporary network analysis would help identify transcriptional pathways responsible for the protective effect of bcl-2 against sepsis-induced apoptosis. This strategy was reported recently to be useful in narrowing the number of potential target genes in a genome-wide study of the host inflammatory response (2). In the current study, two complementary, well-accepted mouse models of sepsis were employed: polymicrobial peritonitis and gram-negative pneumonia. By examining effects of bcl-2 overexpression on changes in RNA abundance that were common to both sepsis models, we hoped to identify functional modules and regulatory nodes by which bcl-2 protects against death from sepsis. Our analysis suggests the novel hypothesis that bcl-2 exerts its protective effects in sepsis by preventing changes in transcriptional networks induced by sepsis, rather than by itself inducing transcriptional changes that alter the septic phenotype. Specifically, our analysis indicates that overexpression of bcl-2 in septic animals altered only one gene (2 probe sets) but prevented alteration in 311 probe sets. In addition, a number of cell death molecular pathways were directly implicated in transcriptional networks, mapped de novo using in silico analysis. Finally, this unbiased analytical approach suggested gene targets for future study, including bcl2L11
(bim , see discussion below ), mycn, and CEACAM1. The latter is a member of the immunoglobulin superfamily that mediates cell-cell adhesion. CEACAM1 , the single gene altered by sepsis in bcl-2 transgenics but not wild-type animals, has been demonstrated to play key roles in T-cell and neutrophil responses, including direct effects on immune regulation, cell growth, proliferation, and survival (15) .
Transcriptional analysis of the response to sepsis in these two models demonstrated distinct differences in the expression of pro-and anti-apoptotic Bcl-2 family members in wild type compared to Bcl-2 transgenic mice ( Figure 4 and Table 2 ). As expected, the abundance of bcl-2 message was increased in bcl-2 transgenic mice. The significance of the observed increase of mycn in the bcl-2 transgenic animals is not known. Of interest, however, a recent report using a mouse model of autoimmune diabetes linked bcl-2 and mycn at the center of gene networks based on the opposing biological process of cell death (bcl-2) and cell proliferation (mycn). (13) Three other bcl-2 family members, mcl-1, bcl2L11 (bim), and bmf, showed altered RNA abundance consistent with increased apoptosis in septic compared to control wild-type animals ( Figure 2) . However, these genes showed no microarray evidence of altered RNA abundance in septic bcl -2 transgenic animals, consistent with the overall effect of bcl-2 to modulate sepsisinduced transcriptional changes, as described above. Mcl-1 has potent anti-apoptotic activity that is critical for the development and maintenance of B and T lymphocytes (12, 16) . Although mcl-1 deficiency results in embryonic lethality, induced deletion of mcl-1 that is restricted to peripheral T and B cells demonstrated that mcl-1 is essential for maintenance of mature lymphocytes (34) . Bim is a member of the pro-apoptotic BH3-only protein family that binds to and inhibits selected members of the anti-apoptotic bcl-2 family (37, 41) . In addition to binding and inhibiting anti-apoptotic bcl-2 proteins, there is evidence that bim may directly induce apoptosis by binding to and activating the pro-apoptotic bcl-2 proteins bax and/or bak (19) . The close interaction between the various members of the pro-and anti-apoptotic bcl-2 family is further highlighted by the fact that mcl-1 binds to bim and may thereby inhibit bim 's proapoptotic activity. Based upon these results and the network depicted in Figure 4 , we investigated subsequently the effect of sepsis on bim null mice (3). Lymphocytes from bim null mice were protected from sepsis-induced apoptotic cell death (3). Moreover, these mice had a greater than three-fold improvement in sepsis survival (p < 0.001). Importantly, even loss of a single allele of bim provided remarkable protection against sepsis induced lymphocyte apo ptosis There are a number of limitations to this study. Most importantly, the tissue samples consisted of whole spleen. We were thus unable to account for the potentially confounding effect of sepsis-induced difference in splenocyte populations. It is important to note, however, that we found no differences in splenocyte cellular populations (such as CD4+ T-cells and Bcells) between sham and CLP mice at the same 6 hour time point (reference (33) and unpublished observations). Given this caveat, we were deliberately conservative in our approach, basing conclusions on similarities across two models of mouse sepsis. We consider the data presented herein to be useful in identifying potential gene targets and regulatory networks, reducing hypothesis space from the 20,000 or so mouse genes that potentially could be involved in the splenic response to sepsis to the few hundred RNA species identified. The large number of genes altered by sepsis and bcl-2 overexpression does not allow for comprehensive validation of the results using other molecular techniques. Instead, we successfully used contemporary network analysis software to identify functional modules of interest and direct our focus towards validating therapeutic targets, including bcl2L11 (bim), as described elsewhere (3).
In conclusion, our data are consistent with alterations in the balance of pro-and antiapoptotic transcriptional networks in spleen 6 hours after septic challenge, with the net result being increased splenocyte apoptosis (23, 24) . In addition, these findings suggest that the ability of bcl-2 overexpression to improve outcome from sepsis in these models is associated with prevention of sepsis-induced alterations in spleen transcriptional responses, including but not limited to decreased RNA abundance of proinflammatory mediators such as IL-6, COX2, and CXCL1. The microarray data from these experiments are available are a resource for the community at the Gene Expression Omnibus (GEO, accession numbers above). Pathway analysis of these data sets suggested important molecular targets for future study, such as bcl2L11 (bim),(3) mycn , and CEACAM1 . Ongoing work using enriched splenocyte populations (such as CD4+ T-cells) will elucidate more clearly the molecular underpinnings and dynamics of these responses (33) . Table 2 for additional gene descriptions and information.
